Resilience

About:

Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.

Website: https://resilience.com

Twitter/X: IncResilience

Top Investors: ARCH Venture Partners, New Enterprise Associates, Google Ventures, 8VC, U.S. International Development Finance Corp

Description:

Resilience is a technology-driven biomanufacturing company committed to expanding access to complex medicines, including biologics, vaccines, nucleic acids, and cell and gene therapies. The company is creating a sustainable network of advanced, end-to-end manufacturing solutions to ensure that today's and tomorrow's treatments can be produced rapidly, safely, and at scale. By continuously innovating in biopharmaceutical manufacturing and development, Resilience enables its partners to focus on breakthrough discoveries that enhance patient outcomes while safeguarding biopharmaceutical supply chains against future disruptions.

Total Funding Amount:

$2.53B

Estimated Revenue Range:

$500M to $1B

Headquarters Location:

La Jolla, California, United States

Founded Date:

2020-01-01

Contact Email:

contact(AT)resilence.com

Hub Tags:

Unicorn

Founders:

Drew Oetting, Rahul Singhvi

Number of Employees:

1001-5000

Last Funding Date:

2024-10-03

IPO Status:

Private

© 2025 bioDAO.ai